BioSpace News Archive

The drug developed by Alkermes took a lot of flack but proved effective in a recent study.

Sage Therapeutics has been on a roll with good news lately.

Nov. 27, 2017 06:00 UTC Ferring Receives Swiss Approval For Rekovelle ® , The First Personalised Fertility Treatment Using an Approved Dosing Algorithm Rekovelle ® provides doctors with an approved, evidence-based, individualised dosing regimen to personalise fertility treatment Approval expands options for fertility patients in Switzerland, providing a new and tailored appr

The trial began shortly after the commencement of rimegepant’s first efficacy trial, Study BHV3000-301, and the two trials enrolled simultaneously with the objective of announcing topline results for the migraine program in the first quarter of 2018.

This unique technology can now be used on a wider range of scanners and provide clinicians with standardized, quantitative measures of the liver tissue to assist with diagnosis of liver disease.

Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD.

For the study, researchers looked at a novel potential way to treat tinnitus by having people use neurofeedback training to turn their focus away from the sounds in their ears.

Scientists behind the research, conducted at NYU School of Medicine, say that studies have long linked the chemicals-famous for keeping food from sticking to pans-with high blood pressure, birth defects, and lower-than-normal birth weights.

The syndicated investment was led by Lumira Capital and included participation from Anges Quebec, Anges Quebec Capital, Accel-Rx Health Sciences Accelerator and a number of Canadian family offices.

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project.